Cas:247237-43-0 methyl 5-chloro-2-[(4-ethoxy-4-oxobutyl)-(4-methylphenyl)sulfonylamino]benzoate manufacturer & supplier

Chemical Name:methyl 5-chloro-2-[(4-ethoxy-4-oxobutyl)-(4-methylphenyl)sulfonylamino]benzoate

CAS.NO:247237-43-0

Synonyms:5-Chloro-2-[(3-ethoxycarbonyl-propyl)-(toluene-4-sulfonyl)-amino]-benzoic acid methyl ester;methyl 5-chloro-2-[N-(3-ethoxycarbonyl)propyl-N-p-toluenesulfonyl]aminobenzoate;I06-1507

Molecular Formula:C₂₁H₂₄ClNO₆S

Molecular Weight:453.93600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.3

Index of Refraction:

PSA:98.36000

Exact Mass:453.10100

LogP:5.05440

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-Chloro-2-[(3-ethoxycarbonyl-propyl)-(toluene-4-sulfonyl)-amino]-benzoic acid methyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,I06-1507 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 5-chloro-2-[N-(3-ethoxycarbonyl)propyl-N-p-toluenesulfonyl]aminobenzoate Use and application,I06-1507 technical grade,usp/ep/jp grade.

Related News: The researchers also found that Black women are much less likely to undergo genetic counseling and testing, largely due to differences in physician recommendations or access to care. methyl 5-chloro-2-[(4-ethoxy-4-oxobutyl)-(4-methylphenyl)sulfonylamino]benzoate manufacturer In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase. methyl 5-chloro-2-[(4-ethoxy-4-oxobutyl)-(4-methylphenyl)sulfonylamino]benzoate supplier Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia. methyl 5-chloro-2-[(4-ethoxy-4-oxobutyl)-(4-methylphenyl)sulfonylamino]benzoate vendor The researchers also found that Black women are much less likely to undergo genetic counseling and testing, largely due to differences in physician recommendations or access to care. methyl 5-chloro-2-[(4-ethoxy-4-oxobutyl)-(4-methylphenyl)sulfonylamino]benzoate factory Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.